ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes (2023)
Sant´Anna, Viviane Aparecida Rodrigues; Izar, Maria Cristina O. ; Fonseca, Henrique Andrade Rodrigues da ; Gidlund, Magnus Ake
Source: European Journal of Internal Medicine. Unidade: ICB
Subjects: IMUNOLOGIA, AUTOANTICORPOS, APOLIPOPROTEÍNAS, EPITOPOS, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANT´ANNA, Viviane Aparecida Rodrigues et al. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. Disponível em: https://doi.org/10.1016/j.ejim.2023.07.018. Acesso em: 13 nov. 2024. , 2023
APA
Sant´Anna, V. A. R., Izar, M. C. O., Fonseca, H. A. R. da, & Gidlund, M. A. (2023). Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. doi:10.1016/j.ejim.2023.07.018
NLM
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
Vancouver
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
Artigo de periodico
NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes (2021)
Costa, Frederico Ribeiro Campos ; Leite, Jefferson Antonio; Rassi, Diane Meyre ; Silva, Josiane Fernandes da ; Oliveira, Jefferson Elias ; Guimarães, Jhefferson Barbosa ; Freitas, Maria Cristina Foss de ; Câmara, Niels Olsen Saraiva ; Pontillo, Alessandra ; Passaglia, Rita de Cassia Aleixo Tostes ; Silva, João Santana da ; Carlos, Daniela
Source: Cell Reports. Unidades: FMRP, ICB
Subjects: IMUNOLOGIA, DIABETES MELLITUS, DOENÇAS AUTOIMUNES, PÂNCREAS, CAMUNDONGOS, POLIMORFISMO, SISTEMA IMUNE, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Frederico Ribeiro Campos et al. NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes. Cell Reports, v. 35, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2021.109176. Acesso em: 13 nov. 2024.
APA
Costa, F. R. C., Leite, J. A., Rassi, D. M., Silva, J. F. da, Oliveira, J. E., Guimarães, J. B., et al. (2021). NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes. Cell Reports, 35, 1-16. doi:10.1016/j.celrep.2021.109176
NLM
Costa FRC, Leite JA, Rassi DM, Silva JF da, Oliveira JE, Guimarães JB, Freitas MCF de, Câmara NOS, Pontillo A, Passaglia R de CAT, Silva JS da, Carlos D. NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes [Internet]. Cell Reports. 2021 ; 35 1-16.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.celrep.2021.109176
Vancouver
Costa FRC, Leite JA, Rassi DM, Silva JF da, Oliveira JE, Guimarães JB, Freitas MCF de, Câmara NOS, Pontillo A, Passaglia R de CAT, Silva JS da, Carlos D. NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes [Internet]. Cell Reports. 2021 ; 35 1-16.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.celrep.2021.109176
Artigo de periodico
Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes (2020)
Bezerra, Daniele Perreira dos Santos ; Ribeiro Junior, Luciano Filgueiras; Monteiro, Maria Beatriz ; Admoni, Sharon Nina ; Perez, Ricardo Vessoni ; Cavaleiro, Ana Mercedes de Sousa; Machado, Cleide Guimarães; Machado, Ubiratan Fabres ; Passarelli, Marisa ; Jancar, Sonia ; Giannella, Maria Lucia Correa
Source: Mediators of Inflammation. Unidades: FM, ICB
Subjects: FISIOLOGIA, IMUNOLOGIA, GLICEMIA, LEUCOTRIENOS, SISTEMA NERVOSO AUTÔNOMO, NEUROPATIAS DIABÉTICAS, DIABETES MELLITUS, EXPRESSÃO GÊNICA, NEFROPATIAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEZERRA, Daniele Perreira dos Santos et al. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/5704713. Acesso em: 13 nov. 2024.
APA
Bezerra, D. P. dos S., Ribeiro Junior, L. F., Monteiro, M. B., Admoni, S. N., Perez, R. V., Cavaleiro, A. M. de S., et al. (2020). Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, 9 . doi:10.1155/2020/5704713
NLM
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2020/5704713
Vancouver
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2020/5704713
Artigo de periodico
Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) (2020)
Davanso, Mariana Rodrigues ; Crisma, Amanda Rabello ; Braga, Tarcio Teodoro ; Masi, Laureane Nunes ; Amaral, Catia Lira do ; Leal, Vinicius Nunes Cordeiro ; Lima, Dhêmerson Souza de ; Patente, Thiago Andrade ; Giannella, Maria Lucia Correa ; Lauterbach, Mario ; Kolbe, Carl Christian ; Latz, Eicke ; Barbuto, José Alexandre Marzagão ; Câmara, Niels Olsen Saraiva ; Pontillo, Alessandra ; Curi, Rui
Source: Clinical Science (Online): an international journal of translational science and medicine. Unidade: ICB
Subjects: FISIOLOGIA, IMUNOLOGIA, DIABETES MELLITUS, ÁCIDOS GRAXOS, MACRÓFAGOS, INFLAMAÇÃO, DOENÇAS AUTOIMUNES, ILHOTAS DE LANGERHANS, MONÓCITOS, HIPERGLICEMIA, CITOCINAS, ÓXIDO NÍTRICO, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVANSO, Mariana Rodrigues et al. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA). Clinical Science (Online): an international journal of translational science and medicine, p. [29 ], 2020Tradução . . Disponível em: https://doi.org/10.1042/CS20201348. Acesso em: 13 nov. 2024.
APA
Davanso, M. R., Crisma, A. R., Braga, T. T., Masi, L. N., Amaral, C. L. do, Leal, V. N. C., et al. (2020). Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA). Clinical Science (Online): an international journal of translational science and medicine, [29 ]. doi:10.1042/CS20201348
NLM
Davanso MR, Crisma AR, Braga TT, Masi LN, Amaral CL do, Leal VNC, Lima DS de, Patente TA, Giannella MLC, Lauterbach M, Kolbe CC, Latz E, Barbuto JAM, Câmara NOS, Pontillo A, Curi R. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) [Internet]. Clinical Science (Online): an international journal of translational science and medicine. 2020 ;[29 ].[citado 2024 nov. 13 ] Available from: https://doi.org/10.1042/CS20201348
Vancouver
Davanso MR, Crisma AR, Braga TT, Masi LN, Amaral CL do, Leal VNC, Lima DS de, Patente TA, Giannella MLC, Lauterbach M, Kolbe CC, Latz E, Barbuto JAM, Câmara NOS, Pontillo A, Curi R. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) [Internet]. Clinical Science (Online): an international journal of translational science and medicine. 2020 ;[29 ].[citado 2024 nov. 13 ] Available from: https://doi.org/10.1042/CS20201348
Artigo de periodico
Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy (2020)
Neves, Jose Antonio Januario; Matos, Mozânia Reis De ; Ramalho, Theresa Raquel de Oliveira ; Bezerra, Daniele Pereira Santos ; Cavalcante, Cristiane Das Graças Dias ; Peixoto, Renata D’ Alpino; Queiroz, Márcia Silva ; Jancar, Sonia ; Giannella, Maria Lucia Correa
Source: Diabetology & Metabolic Syndrome. Unidades: ICB, FM
Subjects: IMUNOLOGIA, DIABETES MELLITUS, RESISTÊNCIA À INSULINA, INFLAMAÇÃO, SISTEMA CARDIOVASCULAR, NEUROPATIAS DIABÉTICAS, SISTEMA NERVOSO AUTÔNOMO, ESTUDOS TRANSVERSAIS, LIPÍDEOS, INTERLEUCINAS, LEUCOTRIENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Jose Antonio Januario et al. Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy. Diabetology & Metabolic Syndrome, v. 12, p. 5 , 2020Tradução . . Disponível em: https://doi.org/10.1186/s13098-020-00606-3. Acesso em: 13 nov. 2024.
APA
Neves, J. A. J., Matos, M. R. D., Ramalho, T. R. de O., Bezerra, D. P. S., Cavalcante, C. D. G. D., Peixoto, R. D. ’ A., et al. (2020). Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy. Diabetology & Metabolic Syndrome, 12, 5 . doi:10.1186/s13098-020-00606-3
NLM
Neves JAJ, Matos MRD, Ramalho TR de O, Bezerra DPS, Cavalcante CDGD, Peixoto RD’ A, Queiroz MS, Jancar S, Giannella MLC. Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy [Internet]. Diabetology & Metabolic Syndrome. 2020 ; 12 5 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13098-020-00606-3
Vancouver
Neves JAJ, Matos MRD, Ramalho TR de O, Bezerra DPS, Cavalcante CDGD, Peixoto RD’ A, Queiroz MS, Jancar S, Giannella MLC. Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy [Internet]. Diabetology & Metabolic Syndrome. 2020 ; 12 5 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13098-020-00606-3
Artigo de periodico
Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice (2020)
Ferreira, Sabrina de Souza ; Oliveira, Maria Aparecida de; Tsujita, Maristela; Nunes, Fernanda Peixoto Barbosa ; Casagrande, Felipe Beccaria; Nascimento, Eliane Aparecida Gomes de Mello; Russo, Momtchilo ; Lima, Wothan Tavares de ; Martins, Joilson de Oliveira
Source: Frontiers in Immunology. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, IMUNOLOGIA, ASMA, DIABETES MELLITUS, INSULINA, HIPERSENSIBILIDADE, CAMUNDONGOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Sabrina de Souza et al. Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice. Frontiers in Immunology, v. 11, p. 14 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.00084. Acesso em: 13 nov. 2024.
APA
Ferreira, S. de S., Oliveira, M. A. de, Tsujita, M., Nunes, F. P. B., Casagrande, F. B., Nascimento, E. A. G. de M., et al. (2020). Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice. Frontiers in Immunology, 11, 14 . doi:10.3389/fimmu.2020.00084
NLM
Ferreira S de S, Oliveira MA de, Tsujita M, Nunes FPB, Casagrande FB, Nascimento EAG de M, Russo M, Lima WT de, Martins J de O. Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice [Internet]. Frontiers in Immunology. 2020 ; 11 14 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.00084
Vancouver
Ferreira S de S, Oliveira MA de, Tsujita M, Nunes FPB, Casagrande FB, Nascimento EAG de M, Russo M, Lima WT de, Martins J de O. Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice [Internet]. Frontiers in Immunology. 2020 ; 11 14 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.00084
Artigo de periodico
NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model (2020)
Sartori, Daniela Carlos ; Pérez, Malena Martínez ; Leite, Jefferson Antonio; Rocha, Fernanda Agostini; Martins, Larissa Marfori Sampaio; Pereira, Camila André; Silva, Thais Fernanda de Campos Fraga da ; Pucci, Taís Andrade; Ramos, Simone Gusmão ; Câmara, Niels Olsen Saraiva ; Bonato, Vânia Luiza Deperon ; Passaglia, Rita de Cassia Aleixo Tostes ; Silva, João Santana da
Source: Frontiers in Immunology. Unidades: FMRP, ICB, FCFRP
Subjects: IMUNOLOGIA, LINFÓCITOS T, DIABETES MELLITUS, INFLAMAÇÃO, OBESIDADE, ADIPOSIDADE, CAMUNDONGOS, RESISTÊNCIA À INSULINA, HIPERGLICEMIA, LINFONODOS DE ANIMAL, EXPRESSÃO GÊNICA, BACTÉRIAS GRAM-NEGATIVAS, BACTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTORI, Daniela Carlos et al. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model. Frontiers in Immunology, v. 11, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.01265. Acesso em: 13 nov. 2024.
APA
Sartori, D. C., Pérez, M. M., Leite, J. A., Rocha, F. A., Martins, L. M. S., Pereira, C. A., et al. (2020). NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model. Frontiers in Immunology, 11, 16 . doi:10.3389/fimmu.2020.01265
NLM
Sartori DC, Pérez MM, Leite JA, Rocha FA, Martins LMS, Pereira CA, Silva TF de CF da, Pucci TA, Ramos SG, Câmara NOS, Bonato VLD, Passaglia R de CAT, Silva JS da. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model [Internet]. Frontiers in Immunology. 2020 ; 11 16 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.01265
Vancouver
Sartori DC, Pérez MM, Leite JA, Rocha FA, Martins LMS, Pereira CA, Silva TF de CF da, Pucci TA, Ramos SG, Câmara NOS, Bonato VLD, Passaglia R de CAT, Silva JS da. NOD2 deficiency promotes intestinal CD4+ T lymphocyte imbalance, metainflammation, and aggravates Type 2 Diabetes in murine model [Internet]. Frontiers in Immunology. 2020 ; 11 16 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.01265
Artigo de periodico
Influence of periodontal disease on cardiovascular markers in diabetes mellitus patients (2019)
Pedroso, Juliana de Fatima ; Lotfollahi, Zahra ; Albattarni, Ghadeer; Schulz, Maiara Arruda; Monteiro, Andrea Moreira; Sehnem, André Luiz; Gidlund, Magnus Ake ; Figueiredo Neto, Antonio Martins ; Jardini, Maria Aparecida Neves
Source: Scientific Reports. Unidades: IF, ICB
Subjects: PERIODONTITE, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, HIPERGLICEMIA, INFLAMAÇÃO, COLESTEROL, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDROSO, Juliana de Fatima et al. Influence of periodontal disease on cardiovascular markers in diabetes mellitus patients. Scientific Reports, v. 9, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-52498-7. Acesso em: 13 nov. 2024.
APA
Pedroso, J. de F., Lotfollahi, Z., Albattarni, G., Schulz, M. A., Monteiro, A. M., Sehnem, A. L., et al. (2019). Influence of periodontal disease on cardiovascular markers in diabetes mellitus patients. Scientific Reports, 9. doi:10.1038/s41598-019-52498-7
NLM
Pedroso J de F, Lotfollahi Z, Albattarni G, Schulz MA, Monteiro AM, Sehnem AL, Gidlund MA, Figueiredo Neto AM, Jardini MAN. Influence of periodontal disease on cardiovascular markers in diabetes mellitus patients [Internet]. Scientific Reports. 2019 ; 9[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-019-52498-7
Vancouver
Pedroso J de F, Lotfollahi Z, Albattarni G, Schulz MA, Monteiro AM, Sehnem AL, Gidlund MA, Figueiredo Neto AM, Jardini MAN. Influence of periodontal disease on cardiovascular markers in diabetes mellitus patients [Internet]. Scientific Reports. 2019 ; 9[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-019-52498-7
Artigo de periodico-carta/editorial
Connecting the dots in type 1 diabetes: the role for gut–pancreas axis (2019)
Silva, Luisa Menezes ; Fonseca, Denise Morais da
Source: Journal of Leukocyte Biology. Unidade: ICB
Subjects: IMUNOLOGIA, DIABETES MELLITUS, PÂNCREAS, EIXOS, INTESTINOS, CAMUNDONGOS, MUCOSA INTESTINAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Luisa Menezes e FONSECA, Denise Morais da. Connecting the dots in type 1 diabetes: the role for gut–pancreas axis. Journal of Leukocyte Biology. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/JLB.3CE0719-242R. Acesso em: 13 nov. 2024. , 2019
APA
Silva, L. M., & Fonseca, D. M. da. (2019). Connecting the dots in type 1 diabetes: the role for gut–pancreas axis. Journal of Leukocyte Biology. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1002/JLB.3CE0719-242R
NLM
Silva LM, Fonseca DM da. Connecting the dots in type 1 diabetes: the role for gut–pancreas axis [Internet]. Journal of Leukocyte Biology. 2019 ; 106( 3): 501-503.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/JLB.3CE0719-242R
Vancouver
Silva LM, Fonseca DM da. Connecting the dots in type 1 diabetes: the role for gut–pancreas axis [Internet]. Journal of Leukocyte Biology. 2019 ; 106( 3): 501-503.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/JLB.3CE0719-242R
Artigo de periodico
Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic (2018)
Soares, Jaine L. S.; Fernandes, Fernanda Pereira; Patente, Thiago Andrade; Monteiro, Maria B.; Parisi, Maria C.; Giannella-Neto, Daniel; Corrêa-Giannella, Maria L.; Pontillo, Alessandra
Source: Clinical Immunology. Unidades: FM, ICB
Subjects: NEFROPATIAS, METABÓLITOS, POLÍMEROS (QUÍMICA ORGÂNICA), INSUFICIÊNCIA RENAL, DIABETES MELLITUS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Jaine L. S. et al. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic. Clinical Immunology, v. 187, p. 46-49, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2017.10.003. Acesso em: 13 nov. 2024.
APA
Soares, J. L. S., Fernandes, F. P., Patente, T. A., Monteiro, M. B., Parisi, M. C., Giannella-Neto, D., et al. (2018). Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic. Clinical Immunology, 187, 46-49. doi:10.1016/j.clim.2017.10.003
NLM
Soares JLS, Fernandes FP, Patente TA, Monteiro MB, Parisi MC, Giannella-Neto D, Corrêa-Giannella ML, Pontillo A. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic [Internet]. Clinical Immunology. 2018 ; 187 46-49.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.clim.2017.10.003
Vancouver
Soares JLS, Fernandes FP, Patente TA, Monteiro MB, Parisi MC, Giannella-Neto D, Corrêa-Giannella ML, Pontillo A. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic [Internet]. Clinical Immunology. 2018 ; 187 46-49.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.clim.2017.10.003
Artigo de periodico
Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model (2017)
Carlos, Daniela ; Costa, Frederico Ribeiro Campos ; Pereira, Camila André; Rocha, Fernanda Agostini; Yaochite, Juliana Navarro Ueda; Oliveira, Gabriela G.; Carneiro, Fernando Silva ; Tostes, Rita de Cássia Aleixo ; Ramos, Simone Gusmão ; Zamboni, Dario Simões ; Câmara, Niels Olsen Saraiva ; Ryffel, Bernhard; Silva, João Santana da
Source: Frontiers in Immunology. Unidades: FMRP, ICB
Subjects: CITOCINAS, DIABETES MELLITUS, DNA MITOCONDRIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Daniela et al. Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.00164. Acesso em: 13 nov. 2024.
APA
Carlos, D., Costa, F. R. C., Pereira, C. A., Rocha, F. A., Yaochite, J. N. U., Oliveira, G. G., et al. (2017). Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.00164
NLM
Carlos D, Costa FRC, Pereira CA, Rocha FA, Yaochite JNU, Oliveira GG, Carneiro FS, Tostes R de CA, Ramos SG, Zamboni DS, Câmara NOS, Ryffel B, Silva JS da. Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2017.00164
Vancouver
Carlos D, Costa FRC, Pereira CA, Rocha FA, Yaochite JNU, Oliveira GG, Carneiro FS, Tostes R de CA, Ramos SG, Zamboni DS, Câmara NOS, Ryffel B, Silva JS da. Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2017.00164
Artigo de periodico
Oral administration of antioxidants improves skin wound healing in diabetic mice (2016)
Pessoa , Ana Flávia Marça; Florim, Juliana Costa; Rodrigues, Hosana Gomes; Oliveira, Vinicius de Andrade; Teixeira, Simone Aparecida; Vitzel, Kaio Fernando; Curi, Rui; Câmara, Niels Olsen Saraiva ; Muscará, Marcelo Nicolás ; Lamers, Marcelo Lazzaron; Santos, Marinilce Fagundes dos
Source: Wound Repair and Regeneration. Unidade: ICB
Subjects: ANTIOXIDANTES, CICATRIZAÇÃO, RATOS, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PESSOA , Ana Flávia Marça et al. Oral administration of antioxidants improves skin wound healing in diabetic mice. Wound Repair and Regeneration, v. 24, n. 6, p. 981-993, 2016Tradução . . Disponível em: https://doi.org/10.1111/wrr.12486. Acesso em: 13 nov. 2024.
APA
Pessoa , A. F. M., Florim, J. C., Rodrigues, H. G., Oliveira, V. de A., Teixeira, S. A., Vitzel, K. F., et al. (2016). Oral administration of antioxidants improves skin wound healing in diabetic mice. Wound Repair and Regeneration, 24( 6), 981-993. doi:10.1111/wrr.12486
NLM
Pessoa AFM, Florim JC, Rodrigues HG, Oliveira V de A, Teixeira SA, Vitzel KF, Curi R, Câmara NOS, Muscará MN, Lamers ML, Santos MF dos. Oral administration of antioxidants improves skin wound healing in diabetic mice [Internet]. Wound Repair and Regeneration. 2016 ; 24( 6): 981-993.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/wrr.12486
Vancouver
Pessoa AFM, Florim JC, Rodrigues HG, Oliveira V de A, Teixeira SA, Vitzel KF, Curi R, Câmara NOS, Muscará MN, Lamers ML, Santos MF dos. Oral administration of antioxidants improves skin wound healing in diabetic mice [Internet]. Wound Repair and Regeneration. 2016 ; 24( 6): 981-993.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/wrr.12486
Artigo de periodico
Influence of the expression of inflammatory markers on kidney after fetal programming in an experimental model of renal failure (2016)
Pereira Júnior, Carlos Donizete Pereira; Guimarães, Camila Souza de Oliveira; Silva, Aline Cristina Souza da; Rodrigues, Aldo Rogelis Aquiles; Glória, Maria Aparecida da; Teixeria, Vicente de Paula Antunes; Câmara, Niels Olsen Saraiva ; Rocha, Lenaldo Branco; Reis, Marlene Antônio dos; Machado, Juliana Reis; Rocha, Laura Penna; Helmo, Fernanda Rodrigues; Corrêa, Rosana Rosa Miranda
Source: Journal of Immunology Research. Unidade: ICB
Subjects: FETO, EXPRESSÃO GÊNICA, INSUFICIÊNCIA RENAL, ÁCIDO FÓLICO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA JÚNIOR, Carlos Donizete Pereira et al. Influence of the expression of inflammatory markers on kidney after fetal programming in an experimental model of renal failure. Journal of Immunology Research, v. 2016, n. ID 9151607, p. 9 , 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/9151607. Acesso em: 13 nov. 2024.
APA
Pereira Júnior, C. D. P., Guimarães, C. S. de O., Silva, A. C. S. da, Rodrigues, A. R. A., Glória, M. A. da, Teixeria, V. de P. A., et al. (2016). Influence of the expression of inflammatory markers on kidney after fetal programming in an experimental model of renal failure. Journal of Immunology Research, 2016( ID 9151607), 9 . doi:10.1155/2016/9151607
NLM
Pereira Júnior CDP, Guimarães CS de O, Silva ACS da, Rodrigues ARA, Glória MA da, Teixeria V de PA, Câmara NOS, Rocha LB, Reis MA dos, Machado JR, Rocha LP, Helmo FR, Corrêa RRM. Influence of the expression of inflammatory markers on kidney after fetal programming in an experimental model of renal failure [Internet]. Journal of Immunology Research. 2016 ; 2016( ID 9151607): 9 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2016/9151607
Vancouver
Pereira Júnior CDP, Guimarães CS de O, Silva ACS da, Rodrigues ARA, Glória MA da, Teixeria V de PA, Câmara NOS, Rocha LB, Reis MA dos, Machado JR, Rocha LP, Helmo FR, Corrêa RRM. Influence of the expression of inflammatory markers on kidney after fetal programming in an experimental model of renal failure [Internet]. Journal of Immunology Research. 2016 ; 2016( ID 9151607): 9 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1155/2016/9151607
Artigo de periodico
The microbiota and chronic kidney diseases: a double-edged sword (2016)
Felizardo, Raphael Jose Ferreira; Castoldi, Angela; Oliveira, Vinicius de Andrade; Câmara, Niels Olsen Saraiva
Source: Clinical & Translational Immunology. Unidade: ICB
Subjects: BIOTA INTESTINAL, NEFROPATIAS, DIABETES MELLITUS, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELIZARDO, Raphael Jose Ferreira et al. The microbiota and chronic kidney diseases: a double-edged sword. Clinical & Translational Immunology, v. 5, p. e86, 2016Tradução . . Disponível em: https://doi.org/10.1038/cti.2016.36. Acesso em: 13 nov. 2024.
APA
Felizardo, R. J. F., Castoldi, A., Oliveira, V. de A., & Câmara, N. O. S. (2016). The microbiota and chronic kidney diseases: a double-edged sword. Clinical & Translational Immunology, 5, e86. doi:10.1038/cti.2016.36
NLM
Felizardo RJF, Castoldi A, Oliveira V de A, Câmara NOS. The microbiota and chronic kidney diseases: a double-edged sword [Internet]. Clinical & Translational Immunology. 2016 ;5 e86.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/cti.2016.36
Vancouver
Felizardo RJF, Castoldi A, Oliveira V de A, Câmara NOS. The microbiota and chronic kidney diseases: a double-edged sword [Internet]. Clinical & Translational Immunology. 2016 ;5 e86.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/cti.2016.36
Artigo de periodico
Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration (2016)
Almeida, Maira Estanislau Soares de; Monteiro, Kelly Salzmann; Kato, Ellen Emi; Vessoni, Sandra Coccuzzo Sampaio; Braga, Tarcio Teodoro; Câmara, Niels Olsen Saraiva ; Lamers, Marcelo Lazzaron; Santos, Marinilce Fagundes dos
Source: Molecular and Cellular Biochemistry. Unidade: ICB
Subjects: GLICOSE, CICATRIZAÇÃO, FIBROBLASTOS, DIABETES MELLITUS, FIBRONECTINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Maira Estanislau Soares de et al. Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration. Molecular and Cellular Biochemistry, v. 421, n. 1-2, p. 19-28, 2016Tradução . . Disponível em: https://doi.org/10.1007/s11010-016-2780-4. Acesso em: 13 nov. 2024.
APA
Almeida, M. E. S. de, Monteiro, K. S., Kato, E. E., Vessoni, S. C. S., Braga, T. T., Câmara, N. O. S., et al. (2016). Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration. Molecular and Cellular Biochemistry, 421( 1-2), 19-28. doi:10.1007/s11010-016-2780-4
NLM
Almeida MES de, Monteiro KS, Kato EE, Vessoni SCS, Braga TT, Câmara NOS, Lamers ML, Santos MF dos. Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration [Internet]. Molecular and Cellular Biochemistry. 2016 ; 421( 1-2): 19-28.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11010-016-2780-4
Vancouver
Almeida MES de, Monteiro KS, Kato EE, Vessoni SCS, Braga TT, Câmara NOS, Lamers ML, Santos MF dos. Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration [Internet]. Molecular and Cellular Biochemistry. 2016 ; 421( 1-2): 19-28.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11010-016-2780-4
Artigo de periodico
Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset (2016)
Costa, Frederico R. C.; Françozo, Marcela C. S.; Oliveira, Gabriela G. de; Ignacio, Aline; Castoldi, Angela; Zamboni, Dario Simões; Ramos, Simone Gusmão; Câmara, Niels Olsen Saraiva ; Zoete, Marcel R. de; Palm, Noah W.; Flavell, Richard A.; Silva, João Santana da; Carlos, Daniela
Source: Journal of Experimental Medicine. Unidades: FMRP, ICB
Subjects: DIABETES MELLITUS, INTESTINOS, BACTÉRIAS, PROTEÍNAS, DOENÇAS AUTOIMUNES, SISTEMA IMUNE, PÂNCREAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Frederico R. C. et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. Journal of Experimental Medicine, v. 213, n. 7, p. 1223-1239, 2016Tradução . . Disponível em: https://doi.org/10.1084/jem.20150744. Acesso em: 13 nov. 2024.
APA
Costa, F. R. C., Françozo, M. C. S., Oliveira, G. G. de, Ignacio, A., Castoldi, A., Zamboni, D. S., et al. (2016). Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. Journal of Experimental Medicine, 213( 7), 1223-1239. doi:10.1084/jem.20150744
NLM
Costa FRC, Françozo MCS, Oliveira GG de, Ignacio A, Castoldi A, Zamboni DS, Ramos SG, Câmara NOS, Zoete MR de, Palm NW, Flavell RA, Silva JS da, Carlos D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset [Internet]. Journal of Experimental Medicine. 2016 ; 213( 7): 1223-1239.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1084/jem.20150744
Vancouver
Costa FRC, Françozo MCS, Oliveira GG de, Ignacio A, Castoldi A, Zamboni DS, Ramos SG, Câmara NOS, Zoete MR de, Palm NW, Flavell RA, Silva JS da, Carlos D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset [Internet]. Journal of Experimental Medicine. 2016 ; 213( 7): 1223-1239.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1084/jem.20150744
Artigo de periodico
Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice (2015)
Carlos, Daniela; Yaochite, Juliana Navarro Ueda; Rocha, Fernanda Agostini; Toso, Vanina Danuza; Malmegrim, Kelen C. R.; Ramos, Simone Gusmão; Jamur, Maria Célia; Oliver, Constance; Câmara, Niels Olsen Saraiva ; Andrade, Marcus Vinicius Melo de; Cunha, Fernando de Queiróz; Silva, João Santana da
Source: European Journal of Immunology. Unidades: FMRP, ICB
Subjects: MASTÓCITOS, DIABETES MELLITUS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Daniela et al. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice. European Journal of Immunology, v. 45, n. 10, p. 2873–2885, 2015Tradução . . Disponível em: https://doi.org/10.1002/eji.201545498. Acesso em: 13 nov. 2024.
APA
Carlos, D., Yaochite, J. N. U., Rocha, F. A., Toso, V. D., Malmegrim, K. C. R., Ramos, S. G., et al. (2015). Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice. European Journal of Immunology, 45( 10), 2873–2885. doi:10.1002/eji.201545498
NLM
Carlos D, Yaochite JNU, Rocha FA, Toso VD, Malmegrim KCR, Ramos SG, Jamur MC, Oliver C, Câmara NOS, Andrade MVM de, Cunha F de Q, Silva JS da. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice [Internet]. European Journal of Immunology. 2015 ; 45( 10): 2873–2885.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/eji.201545498
Vancouver
Carlos D, Yaochite JNU, Rocha FA, Toso VD, Malmegrim KCR, Ramos SG, Jamur MC, Oliver C, Câmara NOS, Andrade MVM de, Cunha F de Q, Silva JS da. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice [Internet]. European Journal of Immunology. 2015 ; 45( 10): 2873–2885.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/eji.201545498
Trabalho de evento-resumo
Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to type 1 diabetes onset (2015)
Ribeiro, Frederico; Françozo, Marcela Cristina Santiago; Zamboni, Dario Simões; Ramos, Simone Gusmão; Câmara, Niels Olsen Saraiva ; Silva, João Santana da; Sartori, Daniela
Source: Abstracts. Conference titles: INNATE IMMUNITY 2015. Unidades: FMRP, ICB
Subjects: DIABETES MELLITUS, INTESTINOS, BACTÉRIAS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Frederico et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to type 1 diabetes onset . 2015, Anais.. Guarujá: SBI, 2015. Disponível em: https://icongresso.itarget.com.br/useradm/anais/?clt=imu.3&lng=I. Acesso em: 13 nov. 2024.
APA
Ribeiro, F., Françozo, M. C. S., Zamboni, D. S., Ramos, S. G., Câmara, N. O. S., Silva, J. S. da, & Sartori, D. (2015). Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to type 1 diabetes onset . In Abstracts. Guarujá: SBI. Recuperado de https://icongresso.itarget.com.br/useradm/anais/?clt=imu.3&lng=I
NLM
Ribeiro F, Françozo MCS, Zamboni DS, Ramos SG, Câmara NOS, Silva JS da, Sartori D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to type 1 diabetes onset [Internet]. Abstracts. 2015 ;[citado 2024 nov. 13 ] Available from: https://icongresso.itarget.com.br/useradm/anais/?clt=imu.3&lng=I
Vancouver
Ribeiro F, Françozo MCS, Zamboni DS, Ramos SG, Câmara NOS, Silva JS da, Sartori D. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to type 1 diabetes onset [Internet]. Abstracts. 2015 ;[citado 2024 nov. 13 ] Available from: https://icongresso.itarget.com.br/useradm/anais/?clt=imu.3&lng=I
Trabalho de evento-resumo
Increased SOCS-1 inhibition of MYD88 expression correlates with milder sepsis-induced ali in diabetic rats (2011)
Ribeiro Junior, Luciano Filgueiras; Martins, Joilson de Oliveira ; Serezani, Carlos Henrique; Montes, Marlise Bonetti Agostinho; Jancar, Sonia
Source: Abstracts. Conference titles: World Congress on Inflammation. Unidades: FCF, ICB
Subjects: DIABETES MELLITUS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO JUNIOR, Luciano Filgueiras et al. Increased SOCS-1 inhibition of MYD88 expression correlates with milder sepsis-induced ali in diabetic rats. 2011, Anais.. Paris: International Association of Inflammation Societies, 2011. . Acesso em: 13 nov. 2024.
APA
Ribeiro Junior, L. F., Martins, J. de O., Serezani, C. H., Montes, M. B. A., & Jancar, S. (2011). Increased SOCS-1 inhibition of MYD88 expression correlates with milder sepsis-induced ali in diabetic rats. In Abstracts. Paris: International Association of Inflammation Societies.
NLM
Ribeiro Junior LF, Martins J de O, Serezani CH, Montes MBA, Jancar S. Increased SOCS-1 inhibition of MYD88 expression correlates with milder sepsis-induced ali in diabetic rats. Abstracts. 2011 ;[citado 2024 nov. 13 ]
Vancouver
Ribeiro Junior LF, Martins J de O, Serezani CH, Montes MBA, Jancar S. Increased SOCS-1 inhibition of MYD88 expression correlates with milder sepsis-induced ali in diabetic rats. Abstracts. 2011 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Cytokine release and selectin expression in the early phase of allergic airway inflammation in diabetic rats: role of insulin (2011)
Martins, Joilson de Oliveira ; Campos, Carlos A. L; Cruz, José Walber Miranda Costa da; Manzolli, Simone; Alves, Venâncio Avancini Ferreira; Vianna, Elcio dos Santos Oliveira; Jancar, Sonia ; Sannomiya, Paulina
Source: Resumos. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental. Unidades: FCF, FM, FMRP, ICB
Subjects: CITOCINAS, DIABETES MELLITUS, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Joilson de Oliveira et al. Cytokine release and selectin expression in the early phase of allergic airway inflammation in diabetic rats: role of insulin. 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 13 nov. 2024.
APA
Martins, J. de O., Campos, C. A. L., Cruz, J. W. M. C. da, Manzolli, S., Alves, V. A. F., Vianna, E. dos S. O., et al. (2011). Cytokine release and selectin expression in the early phase of allergic airway inflammation in diabetic rats: role of insulin. In Resumos. São Paulo: FeSBE.
NLM
Martins J de O, Campos CAL, Cruz JWMC da, Manzolli S, Alves VAF, Vianna E dos SO, Jancar S, Sannomiya P. Cytokine release and selectin expression in the early phase of allergic airway inflammation in diabetic rats: role of insulin. Resumos. 2011 ;[citado 2024 nov. 13 ]
Vancouver
Martins J de O, Campos CAL, Cruz JWMC da, Manzolli S, Alves VAF, Vianna E dos SO, Jancar S, Sannomiya P. Cytokine release and selectin expression in the early phase of allergic airway inflammation in diabetic rats: role of insulin. Resumos. 2011 ;[citado 2024 nov. 13 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation